0001193125-15-185159.txt : 20150611 0001193125-15-185159.hdr.sgml : 20150611 20150513102159 ACCESSION NUMBER: 0001193125-15-185159 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20150513 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cara Therapeutics, Inc. CENTRAL INDEX KEY: 0001346830 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: ONE PARROTT DRIVE CITY: SHELTON STATE: CT ZIP: 06484 BUSINESS PHONE: 203-567-1500 MAIL ADDRESS: STREET 1: ONE PARROTT DRIVE CITY: SHELTON STATE: CT ZIP: 06484 FORMER COMPANY: FORMER CONFORMED NAME: Cara Therapeutics Inc DATE OF NAME CHANGE: 20051213 CORRESP 1 filename1.htm Correspondence Letter

LOGO

May 13, 2015

VIA EDGAR

Ms. Alla Berenshteyn

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549

 

Re: Cara Therapeutics, Inc. (the “Company”)
   Form S-3, File No. 333-203072

Dear Ms. Berenshteyn:

The Company hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective at 4:30 p.m. (Eastern time) on Wednesday, May 13, 2015, or as soon as practicable thereafter.

The Company further acknowledges that:

 

    should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;

 

    the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and

 

    the Company may not assert the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

 

Very truly yours,
CARA THERAPEUTICS, INC.
        By:

/s/ Josef Schoell

Josef Schoell
Chief Financial Officer

cc:    Darren K. DeStefano, Cooley LLP

GRAPHIC 2 g925803img002.jpg GRAPHIC begin 644 g925803img002.jpg M_]C_X``02D9)1@`!`0$!+`$L``#_X@Q824-#7U!23T9)3$4``0$```Q(3&EN M;P(0``!M;G1R4D="(%A96B`'S@`"``D`!@`Q``!A8W-P35-&5`````!)14,@ M0``9&5S8P`````````2D! M\@'Z`@,"#`(4`AT")@(O`C@"00)+`E0"70)G`G$">@*$`HX"F`*B`JP"M@+! M`LL"U0+@`NL"]0,``PL#%@,A`RT#.`-#`T\#6@-F`W(#?@.*`Y8#H@.N`[H# MQP/3`^`#[`/Y!`8$$P0@!"T$.P1(!%4$8P1Q!'X$C`2:!*@$M@3$!-,$X03P M!/X%#044%]@8&!A8&)P8W!D@& M609J!GL&C`:=!J\&P`;1!N,&]0<'!QD'*P<]!T\'80=T!X8'F0>L![\'T@?E M!_@("P@?"#((1@A:"&X(@@B6"*H(O@C2".<(^PD0"24).@E/"60)>0F/":0) MN@G/">4)^PH1"B<*/0I4"FH*@0J8"JX*Q0K<"O,+"PLB"SD+40MI"X`+F`NP M"\@+X0OY#!(,*@Q##%P,=0R.#*<,P`S9#/,-#0TF#4`-6@UT#8X-J0W##=X- M^`X3#BX.20YD#G\.FPZV#M(.[@\)#R4/00]>#WH/E@^S#\\/[!`)$"800Q!A M$'X0FQ"Y$-<0]1$3$3$13Q%M$8P1JA')$>@2!Q(F$D429!*$$J,2PQ+C$P,3 M(Q-#$V,3@Q.D$\43Y10&%"<4211J%(L4K13.%/`5$A4T%585>!6;%;T5X!8# M%B86219L%H\6LA;6%OH7'1=!%V47B1>N%](7]Q@;&$`891B*&*\8U1CZ&2`9 M11EK&9$9MQG=&@0:*AI1&G<:GAK%&NP;%!L[&V,;BANR&]H<`APJ'%(<>QRC M',P<]1T>'4<=:AZ4'KX>Z1\3'SX?:1^4'[\?ZB`5($$@ M;""8(,0@\"$<(4@A=2&A(B>K)]PH#2@_*'$H MHBC4*08I."EK*9TIT"H"*C4J:"J;*L\K`BLV*VDKG2O1+`4L.2QN+*(LURT, M+4$M=BVK+>$N%BY,+H(NMR[N+R0O6B^1+\<-]1B)&9T:K1O!'-4=[1\!( M!4A+2)%(UTD=26-)J4GP2C=*?4K$2PQ+4TN:2^),*DQR3+I-`DU*39--W$XE M3FY.MT\`3TE/DT_=4"=0<5"[40914%&;4>92,5)\4L=3$U-?4ZI3]E1"5(]4 MVU4H5755PE8/5EQ6J5;W5T17DE?@6"]8?5C+61I9:5FX6@=:5EJF6O5;15N5 M6^5<-5R&7-9=)UUX7&EYL7KU?#U]A7[-@!6!78*I@_&%/8:)A]6))8IQB M\&-#8Y=CZV1`9)1DZ64]99)EYV8]9I)FZ&<]9Y-GZ6@_:)9H[&E#:9II\6I( M:I]J]VM/:Z=K_VQ7;*]M"&U@;;EN$FYK;L1O'F]X;]%P*W"&<.!Q.G&5&YXS'DJ>8EYYWI& M>J5[!'MC>\)\(7R!?.%]07VA?@%^8G["?R-_A'_E@$>`J($*@6N!S8(P@I*" M](-7@[J$'82`A..%1X6KA@Z&I+CDTV3MI0@E(J4 M])5?EAMJ(FHI:C!J-VH^:D5J3'I3BEJ:8:IHNF_:=NI^"H M4JC$J3>IJ:H_ MR#W(O,DZR;G*.,JWRS;+MLPUS+7--:6YQ_GJ>@RZ+SI1NG0ZEOJ MY>MPZ_OLANT1[9SN*.ZT[T#OS/!8\.7Q7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*S MM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ M_\0`'P$``P$!`0$!`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0# M!`<%!`0``0)W``$"`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1 M"A8D-.$E\1<8&1HF)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI M:G-T=79W>'EZ@H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZ MPL/$Q<;'R,G*TM/4U=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1 M`Q$`/P#]4ZBN;J*R@>>[DCAAB4L\DC!54#J23T%0:QJ]IH.F7.H:K,EO:6<1 MDFD;HJCK_P#JKY`\5^-_$_[1'C%-$\,QS0:47S!9E]J(BGF:\%^'YW@LIKO6IH\@FPC!C!_WV(!^JYKE[;]L32' MN`+SP]J,4'=X[A';_OD@#]:V_!?[+/A;1+2-_$XEUV^(!_`+P%?0F.3PY:1#LT$DD3#\585ARXZ6MTO(G]XRWX(^,?A7Q^ZPZ#J M*K>L/^/.Y'E3'C)PI^]@`YVDUVU>):#^SC;^"OB/H_B#PM?R/I]I+(9[.[Y= M`T;J"C@<\L.".G.3TKVVNK#RJN+]HK,N+E;4*0G`I:\Z^.WCW_A`_`%Y/;2; M-0O_`/1;+!Y#L#EQ_NKD_7%75J*G!R?0;=ERV< MQR/OH<$CU!!!!]#6[7QO^S#X[/ACQW_9-Y(18^(%$/S'A9UYC//KEE]RP]*^ MQP^&;C6M1@GN8+=XU,<&-QWL%&,D#O M71UY3^TW_P`DBU/_`*[V_P#Z.6M:TG&G*2W2')VBVF0>/0]*\ZG/&NFJB::[&474:N>V6=[!J%M'<6,T5Q!,H:.6)PRNIZ$$< M$5/7RE^R_P"-M0T+QC<>#]6:7[-=>;Y,,A_X]KB/)8#T!`;(]0/?/U8.E=V& MKJM3YC6$N97%J.>>.V@DFN'6.*)"[NYP%4#))/85)7BW[4/CW_A&O!:Z-8RE M+_Q`3&Q4X*6Z_P"L/XY"^X9O2KK552@YOH.3LKGJ?A7Q/8^,=!M-7T5VDL[U M"T988(P2"".Q!!%:U?,/[)/CKRKJ_P#"EY)\LV;NQW'^(#$B#\,,![-7T]48 M:M[:DI"A+F5PHHHKH*/G;]KKQ=)::9I/AVTE*"_9KF[`;&Z-"`BGV+9/U05V M?[.G@"W\(^`+*^DC']IZ[&MU<2D<[&YC3V`4@X]2:\4_:U#_`/"S+;?G9_9$ M6W/3_629KZM\+R13>&=(DM,>0]C"T6.FTH,?I7F4/?QM/#.A,7M["X^PP8&1YI/[Z0]\+C'T3/>OHKX MO^.D^'W@34-31U%XZ^18J?XIG!"\=\%1Y;D_P!YE7\T)[U]'_#+QE%X]\%:9K,)427$6VX0?P3+\KCZ;@<> MQ%-^)_@Q/'G@?5-'(7SIXB]JS?P3+\R'/;D`'V)KP/\`94\:/HGB#4O"6JYA M-\[2V\<@P4N(QB1,8ZE1_P"0_>A15#$^4OS#X9^3/J>O*?VF_P#DD6I_]=[; M_P!'+7JU>4_M.VWEW#8VLMQ=R)%#"A>1W.%50,DD]ABOB+X>_%+QC\/?"]X/"UE&^D"[,MQ M=2V+R)'(RJN"X(4#ZUJQ>(/B;\?%FT^RG,]@C*+J*!DMH8P>AD_B8<$XY MZ=.*\VAC8QI1@DW*QE&HDDK:DWP@<^*_VBCJFF(WV5KZ]OB<8V1,),$_BZC\ M:^QQTKS?X-?!RT^%NF2M+(MYK%\H^UW0&`H'_+-,\[0>_4GD]@/2:[,%1E3I M^]N]2Z<6EJ,DD6*-GD8*J`EB3@`#J:^,=3GG^/\`\;XX8BYTV2?RHR./+LHB M2S>Q8;CSW<"O:WY$+_`,#SVKF_V3/` MQL-$O?%%['B;4V^SV9(Z0(?F8>S.,?\``/>L,3^_KQH]%JR9^])1//\`XNZ' M/\'/C!8Z]X?A$%ED;' MSM^UUX1ENM+TKQ%:1LXL'-M=[5SA'(*,?8-D?5Q76?LW>/H/%7@*UTV:51J. M@QBUEBSRT0XC<>VW"_537J&LZ/::_I=UI^JPI<6EY&8YHWZ,IZ__`*Z^/O&7 MP^\4?`+Q2NM^&9IY-,BD_P!'OU&0$)_U4ZCCT'/!X(P>!YE=2P];VR5T]S&5 MXRYEL?9U%>!^#?VM-#O[:.+QE:7.EW2@!YH$,T+GUP/F7Z8/UKJK[]I?P!:6 MYDAU>:[8=(H+*7B M:%9?V?H\\TOGO.0TTX6)V`P.$&0#P2>.O:O6?B/XPB\"^#-4UB?!>UA(@0_Q MRMPB_P#?1&?;-53Q-.<7*+T0U)-7/FC]I_QJ_BGQM!X?THM-;:(-C)'\WF7+ MXW``=<#:OJ#N%4/"?Q?\?>"]!M-'T/1(4L[-2$WZ9*S,2222<\DDDFMC]E_P M=+XK\;7WBG6MUQ'I;%EDD&?-NIH%7 MB,%5<.;G;:U"5.5MSM?"?B*W\6>'-/U?3SF"_@651G)4D6I/*GMYBG]0#T//K7[(?_)/]4_[# M$G_HJ*NZ^,'PSM_B9X3FLF*0ZA;9ET^X8?ZN3'W2?[K=#^!["N>-!U,-"4?B M6Q*C>":W.LT/6K/Q#I-IJ.DS+<6EY$LD4B]P1G\#ZCL:NNX12S'``R2>U?)O M[//Q-G\">)9_!_BHM;VES=-%&)3C['<@X*GT5CP?0X/FZ;H>B1VMC`D,*FUG)" MJ,#/[SKQ77_LE>`@(+_Q7?Q@M(3:6&\=%&/,[CJ$X22O?8]PM;B.[MXI[=UDBF0.CJ,*%R MV3TQCDUJ/]T\5O&/-,)4#=G'7OTK70HYG7/ M@/\`#SQ3>LL=C%97DD2S_P#$OF,/[MB0K!!\@!(/.WM7,Z=^SK\-3KKZWT!_>63WR;A@`X(501P0>M>D>$_"-UH/B!KF:2[G@DT:WMR]S<^:5E5W+( M.X4`CVYIGAW1=0TWQIK5Q=6NH"UO[UIX9UOD^SE3%&OS1;L[LH><>E<[PE!N M[BB.2/87PQH'@CP1JPTCPY;Z1I^JNF1"&!N77&?O,2YX!/7L:3XH^`=&\>Z; M96_BN_O;.R@N5\M+>94629R$3.5.3EL#_>-5K[PKJK_$A-91>L3P%K<2(O MS"%T$P[DH6(VYY#$@$@5+\0_"&K>-[RUL[2>VL=.LXGG\Z:(S;[E@40JJNI! MC!+`GC++P<<:^RI\O+;0=E:Q>\+>%]!^$GA3[+9S?9=-MY#)-PJHQC%)(>QNZ?K^G:K8/>Z;>07%I&6#S1ME5VC)Y]A3XM M5LKR2&&&XAE>YM_M$2*V2\7`WCV^9>?>LG1--N9?#-S9WD6H6LLZR1@:A=K< MR#$Q&,;L$[N@ MQR]!G)>%OA/X#T/XA"\\-ZS=)KMG/)(;&.[0A,[@Z%-N=N"1C/;K7?>,?#6D M_$G0[[0=1NI?)66,7/V615DC==LB@Y!`R"IZ=#5VTTVXB\8ZE?N@^RW.G6L, M;[ARZ23EACKTD7\ZCT'2KFQUSQ+A^$_A[]J\->%]7^U7,MT\TD$]PDDHD"@,OR@#@*"1U%=? M<>(M+MM6ATNYOK6/4)UW16S2`.PYQ@>^UL>N#Z&L#P19ZIX>M;30[W2@\-DT M@.JK<(4F!R1)MSO\QB?FR,9).34.J:/JY\=V][I%H;>%VA6ZO5NE,4\"A]R2 M1'GS`3\K*.C6?M/?"0W]J_B_P]`#&W=5O]5'V.U]07!WO_P`!7<<^N*^/=%&O>$DTOQ7ID4UM#'>,EI=X M^1I4`W(?4$$CT(W#L<>%CXPC6]W9[G-524C[Y\,^'[7PKH-CI.F+MM;"!8H\ M]3CJ3[DY)]S6I7*?#7Q]9?$;PO;:MI^(Y&&RY@)R8)0/F4_S![@BNKKW*;BX MIQV.E6MH%5=4TV#6--NK&_C$MM>0M#,AZ,C`@C\C5JBJ:OH,\T^'OP(T;X:Z MXVI^'M2UEY)(6AEBN)8V2120>0$!X(!R#_6O2Z**F%.,%:*LA))*R,_7M&A\ M0:3/<10W2;'>WE,;@9S\K#D'BN&_X4-H/_02\4?^#J7_`!KTFBE*E"3O M)7!Q3W/-O^%"Z#_T$O%'_@YE_P`:/^%#:#_T$O%'_@ZE_P`:])HJ?J]+^5"Y M(]CS;_A0V@_]!+Q1_P"#J7_&C_A0V@_]!+Q1_P"#J7_&O2:*/J]+^5!R1['F MW_"AM!_Z"7BC_P`'4O\`C1_PH;0?^@EXH_\`!U+_`(UZ311]7I?RH.2/8\V_ MX4-H/_02\4?^#J7_`!H_X4-H/_02\4?^#J7_`!KTFBCZO2_E0*/_!U+_C7I-%'U>E_*@Y(]CRN__9O\)ZIL_M.;7KOR M\[//U223;GKC/3I72W'PK\/77@B+PG+:,='A50B!SO4AMVX-UW9))/N:Z^BA M8>DKVBM044NAQ?@/X2Z%\-Y[J3PQ]NC%XJK-'-<&1&V]#CU&3S[UVE%%:0A& 1"M%60TDM@HHHJAA1110!_]D_ ` end